Icahn School of Medicine at Mount Sinai Joins Drug-Induced Liver Injury Network
September 10, 2013
Mount Sinai has joined the Drug-Induced Liver Injury Network of the NIH to better undrestand drug-induced liver injury, which affects one million people each year.
Mount Sinai Invents Gene Signature to Identify Individuals with Cirrhosis at High-Risk for Liver Cancer
April 17, 2013
Mount Sinai researchers have developed the first gene test to identify patients with cirrhosis who are at highest risk of developing liver cancer.
Mount Sinai Appoints Scott L. Friedman, MD, Dean for Therapeutic Discovery
March 19, 2012
This newly created position highlights Mount Sinai’s emerging role in the development of novel drugs and diagnostic products.
NY 1 – “Boomers Urged To Get Hep C Tests To Counter Rising Liver Disease Deaths”
February 26, 2012
The blood-borne liver disease, hepatitis C can go undetected for decades. Federal health officials say that is a huge part of the reason why two-thirds of the more than three million Americans infected and most at risk are baby boomers.
Examiner.com - Dr. Douglas Dieterich: “Hepatitis C: Won't Happen To Me”
January 16, 2012
An estimated 3.2 million people in the U.S. have Hepatitis C. About 17,000 new Hepatitis C infections occur every year.
Motherhood Moment - Dr. Douglas Dieterich: “Healthy Habits: Hepatitis C”
January 9, 2012
Dr. Douglas Dieterich, Professor of Medicine Division of Liver Diseases at The Mount Sinai Medical Center, and former Hepatitis C patient who has dedicated his career to researching new ways to treat the virus says Hepatitis C is one of the most curable viruses if proper steps are taken.
U.S. News and World Report Ranks The Mount Sinai Kravis Children’s Hospital Among the Nation’s Best
May 17, 2011
Mount Sinai recognized for providing distinguished pediatric care in gastroenterology, nephrology, diabetes/endocrinology, and pulmonology.
The Days of Wine and Cirrhosis
July 14, 2010
Fibrosis is a term doctors use to describe the scarring of the liver that builds up over time as the result of liver damage. A healthy liver has many vital functions. Find out more from Dr. Friedman.
UNOS Approves RMTI Treatment Protocol for Patients with Hilar Cholangiocarinoma
July 14, 2010
RMTI’s protocol for treating patients with hilar cholangiocarcinoma (CCA) was approved by the UNOS Liver and Intestinal Organ Transplantation Committee on June 17, 2010, offering new hope for CCA patients who ordinarily would not qualify for transplantation.
The Mount Sinai Hospital Ranked in Top 25 of Best Children’s Hospitals in Two Specialties by U.S. News and World Report
June 4, 2010
Mount Sinai’s Kravis Children’s Hospital is cited for excellence in pediatric gastroenterology and kidney disease.
Dianne LaPointe Rudow, DNP, Pioneers Living Donor Wellness Center at The Mount Sinai Medical Center
April 26, 2010
Dianne LaPointe Rudow, DNP joins The Mount Sinai Medical Center to head the nation’s first multi-organ Living Donor Wellness Center.